The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma

被引:9
|
作者
Qin, Jiali [1 ]
Yang, Yang [1 ,2 ]
Du, Wei [1 ,3 ]
Li, Gang [1 ]
Wu, Yao [1 ]
Luo, Ruihua [1 ]
Liu, Shanting [1 ]
Fan, Jie [1 ]
机构
[1] Zhengzhou Univ, Henan Canc Hosp, Dept Head Neck & Thyroid Surg, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Anat, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
follicular thyroid carcinoma; metabonomics; lipid metabolites; RAS; LysoPA; LYSOPHOSPHATIDIC ACID; METABOLOMICS; EXPRESSION; NODULES; CANCER;
D O I
10.3389/fonc.2022.1076548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTo explore the metabolic differences of follicular thyroid carcinoma (FTC) by metabonomics, to find potential biomarkers for the diagnosis of FTC, and to explore the pathogenesis and diagnosis and treatment strategies of FTC. MethodThe metabonomics of 15 patients with FTC and 15 patients with follicular thyroid nodules(FTN) treated in Henan Cancer Hospital were analyzed by liquid chromatography-mass spectrometry (LC-MS). ResultsThe analysis showed that the metabolite profiles of FTC tissues could be well distinguished from those of control tissues, and 6 kinds of lipids were identified respectively, including lysophosphatidic acid(LysoPA) [LysoPA(0:0/18:0),LysoPA(0:0/18:2(9Z,12Z)],LysoPA[20:4(8Z,11Z,14Z,17Z)/0:0)]; phosphatidic acid(PA) [PA(20:3(8Z,11Z,14Z)/0:0),PA(20:4(5Z,8Z,11Z,14Z)/0:0),PA(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)]; lysophosphatidylcholine(LPC) [LPC(18:1),LPC(16:0),LPC[16:1(9Z)/0:0],LPC(17:0),LPC[22:4(7Z,10Z,13Z,16Z),LPC(20:2(11Z,14Z); phosphatidylcholine(PC)(PC(14:0/0:0),PC(16:0/0:0); sphingomyelin(SM) (d18:0/12:0); fatty acid(FA)(18:1(OH3)]. There are 2 kinds of amino acids, including L-glutamate,L-glutamine.There are 3 other metabolites, including retinol,flavin adenine dinucleotide,androsterone glucuronide.Lipid metabolites are the main metabolites in these metabolites.The metabolic pathways related to FTC were analyzed by KEGG and HMDB, and 9 metabolic pathways were found, including 4 amino acid related metabolic pathways, 1 lipid metabolic pathways and 4 other related pathways. ConclusionThere are significant differences in many metabonomic characteristics between FTC and FTN, suggesting that these metabolites can be used as potential biomarkers. Further study found that LysoPA and its analogues can be used as biomarkers in the early diagnosis of FTC.It may be related to the abnormal metabolism of phospholipase D (PLD), the key enzyme of LysoPA synthesis caused by RAS pathway. At the same time, it was found that the metabolic pathway of amino acids and lipids was the main metabolic pathway of FTC. The abnormality of LysoPA may be the cause of follicular tumor carcinogenesis caused by lipid metabolic pathway.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Non-targeted mercapturic acid screening in urine using LC-MS/MS with matrix effect compensation by postcolumn infusion of internal standard (PCI-IS)
    Bloch, Robert
    Schuetze, Susann-Elisabeth
    Mueller, Erik
    Roeder, Stefan
    Lehmann, Irina
    Brack, Werner
    Krauss, Martin
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2019, 411 (29) : 7771 - 7781
  • [42] Non-targeted mercapturic acid screening in urine using LC-MS/MS with matrix effect compensation by postcolumn infusion of internal standard (PCI-IS)
    Robert Bloch
    Susann-Elisabeth Schütze
    Erik Müller
    Stefan Röder
    Irina Lehmann
    Werner Brack
    Martin Krauss
    Analytical and Bioanalytical Chemistry, 2019, 411 : 7771 - 7781
  • [43] Geographical Origin Differentiation of Rice by LC-MS-Based Non-Targeted Metabolomics
    Li, Zhanming
    Tan, Mengmeng
    Deng, Huxue
    Yang, Xu
    Yu, Yue
    Zhou, Dongren
    Dong, Hao
    FOODS, 2022, 11 (21)
  • [44] Non-Targeted LC-MS Metabolomics Approach towards an Authentication of the Geographical Origin of Grain Maize (Zea mays L.) Samples
    Schuetz, David
    Achten, Elisabeth
    Creydt, Marina
    Riedl, Janet
    Fischer, Markus
    FOODS, 2021, 10 (09)
  • [45] A Non-Targeted LC-MS Metabolic Profiling from the Cord Plasma of Newborns from Preeclamptic and Control Pregnancies - The Finnpec Study.
    Jaaskelainen, Tiina
    Krkkinen, Olli
    Jokkala, Jenna
    Sarkkinen, Kaisa
    Heinonen, Seppo
    Auriola, Seppo
    Lehtonen, Marko
    Hanhineva, Kati
    Laivuori, Hannele
    REPRODUCTIVE SCIENCES, 2018, 25 : 239A - 239A
  • [46] Characterization and annotation of oxidized glycerophosphocholines for non-targeted metabolomics with LC-QTOF-MS data
    Gil de la Fuente, Alberto
    Traldi, Federico
    Siroka, Jitka
    Kretowski, Adam
    Ciborowski, Michal
    Otero, Abraham
    Barbas, Coral
    Godzien, Joanna
    ANALYTICA CHIMICA ACTA, 2018, 1037 : 358 - 368
  • [47] A Non-Targeted LC-MS Profiling Reveals Elevated Levels of Carnitine Precursors and Trimethylated Compounds in the Cord Plasma of Pre-Eclamptic Infants
    Jaaskelainen, Tiina
    Karkkainen, Olli
    Jokkala, Jenna
    Litonius, Kaisa
    Heinonen, Seppo
    Auriola, Seppo
    Lehtonen, Marko
    Hanhineva, Kati
    Laivuori, Hannele
    SCIENTIFIC REPORTS, 2018, 8
  • [48] A Non-Targeted LC-MS Profiling Reveals Elevated Levels of Carnitine Precursors and Trimethylated Compounds in the Cord Plasma of Pre-Eclamptic Infants
    Tiina Jääskeläinen
    Olli Kärkkäinen
    Jenna Jokkala
    Kaisa Litonius
    Seppo Heinonen
    Seppo Auriola
    Marko Lehtonen
    Kati Hanhineva
    Hannele Laivuori
    Scientific Reports, 8
  • [49] Non-Targeted LC-MS/MS Assay for Screening Over 100 Lipid Mediators from ARA, EPA, and DHA in Biological Samples Based on Mass Spectral Fragmentations
    Dasilva, Gabriel
    Munoz, Silvia
    Lois, Salome
    Medina, Isabel
    MOLECULES, 2019, 24 (12):
  • [50] Non-targeted LC–MS/MS metabolomic profiling of human plasma uncovers a novel Mediterranean diet biomarker panel
    Shirin Macias
    Ali Yilmaz
    Joseph Kirma
    Sarah E. Moore
    Jayne V. Woodside
    Stewart F. Graham
    Brian D. Green
    Metabolomics, 20